معرفی
Ronald Guido is an Adjunct Lecturer in Biological Sciences at Columbia University and Senior Vice-President of Regulatory Affairs and Quality Systems at Brooklyn ImmunoTherapeutics. With over 40 years in pharmaceutical development, he has expertise in preclinical screening, clinical research, and regulatory strategy for drugs, devices, and biologics.
His teaching focuses on regulatory pathways for biotechnology products, international compliance, and product development lifecycle management. Professional experience includes senior roles at Veloxis, Pfizer, Retrophin, and Wyeth Ayerst Laboratories.
He holds an MSc in Pharmaceutical Medicine from Hibernia College and an MS in Technical Communications from Polytechnic University.
۰مقاله منتشرشده
